Janssen Research & Development LLC
US H-1B Labor Condition Application activity for Janssen Research & Development LLC. Filed 302 disclosures between FY2012 and FY2026 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of Janssen Research & Development LLC’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 99.3% |
| Withdrawn | 0.3% |
| Denied | 0.3% |
Top occupations sponsored
SOC codes filed most by Janssen Research & Development LLC across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-1042 | Medical Scientists, Except Epidemiologists | 59 |
| 2 | 15-2041 | Statisticians | 28 |
| 3 | 15-2051 | Data Scientists | 25 |
| 4 | 19-1022 | Microbiologists | 24 |
| 5 | 19-1029 | Biological Scientists, All Other | 12 |
| 6 | 19-1021 | Biochemists and Biophysicists | 11 |
| 7 | 15-1252 | Software Developers | 7 |
| 8 | 13-1041 | Compliance Officers | 5 |
| 9 | 19-2031 | Chemists | 3 |
| 10 | 15-1221 | Computer and Information Research Scientists | 3 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2012 | 13 |
| FY2013 | 8 |
| FY2014 | 14 |
| FY2015 | 20 |
| FY2016 | 10 |
| FY2017 | 11 |
| FY2018 | 11 |
| FY2019 | 24 |
| FY2020 | 9 |
| FY2021 | 18 |
| FY2022 | 15 |
| FY2023 | 13 |
| FY2024 | 42 |
| FY2025 | 63 |
| FY2026 | 31 |
| Period | Value |
|---|---|
| FY2012 | 13 |
| FY2013 | 8 |
| FY2014 | 14 |
| FY2015 | 20 |
| FY2016 | 10 |
| FY2017 | 11 |
| FY2018 | 11 |
| FY2019 | 24 |
| FY2020 | 9 |
| FY2021 | 18 |
| FY2022 | 15 |
| FY2023 | 13 |
| FY2024 | 42 |
| FY2025 | 63 |
| FY2026 | 31 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.